Raredr

NORD Goes Live with Q&A about American Health Care Act and Other Policies

Published Online: Thursday, Mar 16, 2017
Tim Boyd and Paul Melmeyer from NORD's policy team were on Facebook Live earlier today. Below is their posting. Tim and Paul talked for over 50 minutes about various policy issues relevant to the rare disease community, including the Affordable Care Act, and its proposed replacement, the American Health Care Act.


For more information, visit www.raredisease.org and visit our NORD partner page at www.raredr.com/sap-partner/nord
 

Latest Articles
Dr Michael Davidson of the University of Chicago School of Medicine discusses why a proper diagnosis is so valuable to FCS patients.
CRPS is often difficult to diagnose and in Jones’ case, that was also true. His symptoms appeared suddenly while playing high school football.
At the 2017 NLA Sessions, Rare Disease Report sat with dietician Wahida Karmally from Columbia University to discuss the necessary diet for FCS patients.
Michael Weschler, MD presents data at the 2017 American Thoracic Society Conference that shows the FDA-approved mepolizumab helps in the treatment of EGPA.
$vacMongoViewPlus$ $vAR$